Updates are available Correction dated 2018-03-29

Click to view Correction: https://doi.org/10.1007/s40257-018-0353-x

Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders: A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3)

Crossref DOI link: https://doi.org/10.1007/s40257-016-0246-9

Published Online: 2017-01-10

Published Print: 2017-04

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark